摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 6-({4'-[2-ethoxy-2-(5-propyl-[1,3,4]oxadiazol-2-yl)ethyl]biphenyl-3-ylmethyl}methylcarbamoyl)naphthalene-2-carboxylate | 692780-77-1

中文名称
——
中文别名
——
英文名称
methyl 6-({4'-[2-ethoxy-2-(5-propyl-[1,3,4]oxadiazol-2-yl)ethyl]biphenyl-3-ylmethyl}methylcarbamoyl)naphthalene-2-carboxylate
英文别名
Methyl 6-[[3-[4-[2-ethoxy-2-(5-propyl-1,3,4-oxadiazol-2-yl)ethyl]phenyl]phenyl]methyl-methylcarbamoyl]naphthalene-2-carboxylate
methyl 6-({4'-[2-ethoxy-2-(5-propyl-[1,3,4]oxadiazol-2-yl)ethyl]biphenyl-3-ylmethyl}methylcarbamoyl)naphthalene-2-carboxylate化学式
CAS
692780-77-1
化学式
C36H37N3O5
mdl
——
分子量
591.707
InChiKey
CHLKXJPJESHSCZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.7
  • 重原子数:
    44
  • 可旋转键数:
    13
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.28
  • 拓扑面积:
    94.8
  • 氢给体数:
    0
  • 氢受体数:
    7

文献信息

  • Novel biaromatic compounds which activate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof
    申请人:Clary Laurence
    公开号:US20060004048A1
    公开(公告)日:2006-01-05
    Novel biaromatic compounds having the structural formula (I) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively, into cosmetic compositions.
    具有以下结构式(I)的新型双芳香化合物被制成适用于人类或兽医药物的制剂(在皮肤科,以及心血管疾病,免疫疾病和/或与脂质代谢有关的疾病领域),或者,制成化妆品制剂。
  • Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
    申请人:Clary Laurence
    公开号:US20080070957A1
    公开(公告)日:2008-03-20
    Novel biaromatic compounds having the structural formula (I) below: are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively, into cosmetic compositions.
    具有以下结构式(I)的新型双芳香族化合物被制成适用于人类或兽医药物(在皮肤科以及心血管疾病、免疫性疾病和/或与脂质代谢相关的疾病领域)的制剂,或者是化妆品制剂。
  • US7285568B2
    申请人:——
    公开号:US7285568B2
    公开(公告)日:2007-10-23
  • US7582663B2
    申请人:——
    公开号:US7582663B2
    公开(公告)日:2009-09-01
查看更多